Azetirelin
Alternative Names: YM 14673Latest Information Update: 09 Aug 2002
At a glance
- Originator Yamanouchi
- Class Antidementias; Antidepressants; Hormones; Neuroprotectants
- Mechanism of Action Thyrotropin-releasing hormone stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Alzheimer's disease; Neurological disorders
Most Recent Events
- 13 Oct 1998 Profile reviewed
- 09 Dec 1996 Phase-III clinical trials for Cerebrovascular disorders in Japan (Unknown route)
- 15 Aug 1996 Phase-III clinical trials for Neurological disorders in Japan (Unknown route)